Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?

Burgers JA, Damhuis RA.

ERJ Open Res. 2018 Nov 5;4(4). pii: 00030-2018. doi: 10.1183/23120541.00030-2018. eCollection 2018 Oct.

2.

Ultra-sensitive LC-MS/MS method for the quantification of gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma for a microdose clinical trial.

van Nuland M, Hillebrand MJX, Rosing H, Burgers JA, Schellens JHM, Beijnen JH.

J Pharm Biomed Anal. 2018 Mar 20;151:25-31. doi: 10.1016/j.jpba.2017.12.048. Epub 2017 Dec 26.

PMID:
29294409
3.

Older Patients' Recall of Online Cancer Information: Do Ability and Motivation Matter More than Chronological Age?

Bol N, Smets EMA, Burgers JA, Samii SM, De Haes HCJM, Van Weert JCM.

J Health Commun. 2018;23(1):9-19. doi: 10.1080/10810730.2017.1394400. Epub 2017 Dec 11.

PMID:
29227736
4.

A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).

Boshuizen RC, Vd Noort V, Burgers JA, Herder GJM, Hashemi SMS, Hiltermann TJN, Kunst PW, Stigt JA, van den Heuvel MM.

Lung Cancer. 2017 Jun;108:9-14. doi: 10.1016/j.lungcan.2017.01.019. Epub 2017 Feb 16.

PMID:
28625655
5.

Late complications of bariatric surgery in pregnancy.

Reijnierse A, Burgers JA, Go AT, Zengerink JF, van der Weiden RM.

JRSM Open. 2016 Nov 1;7(11):2054270416660935. eCollection 2016 Nov.

6.

Peri- and postoperative management of stage I-III Non Small Cell Lung Cancer: Which quality of care indicators are evidence-based?

Numan RC, Berge MT, Burgers JA, Klomp HM, van Sandick JW, Baas P, Wouters MW.

Lung Cancer. 2016 Nov;101:129-136. doi: 10.1016/j.lungcan.2016.06.007. Epub 2016 Jun 14. Review.

PMID:
27794401
7.

Pre- and postoperative care for stage I-III NSCLC: Which quality of care indicators are evidence-based?

Numan RC, Berge MT, Burgers JA, Klomp HM, van Sandick JW, Baas P, Wouters MW.

Lung Cancer. 2016 Nov;101:120-128. doi: 10.1016/j.lungcan.2016.05.022. Epub 2016 Sep 22. Review.

PMID:
27794400
8.

[Financial compensation for asbestosis patients].

Hagmolen Of Ten Have W, Rooijackers JM, Burgers JA.

Ned Tijdschr Geneeskd. 2016;160:D544. Dutch.

PMID:
27781966
9.

Spectral sensing for tissue diagnosis during lung biopsy procedures: The importance of an adequate internal reference and real-time feedback.

Spliethoff JW, de Boer LL, Meier MAJ, Prevoo W, de Jong J, Bydlon TM, Sterenborg HJCM, Burgers JA, Hendriks BHW, Ruers TJM.

Lung Cancer. 2016 Aug;98:62-68. doi: 10.1016/j.lungcan.2016.05.019. Epub 2016 May 26.

PMID:
27393508
10.

A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†.

Dingemans AM, Groen HJ, Herder GJ, Stigt JA, Smit EF, Bahce I, Burgers JA, van den Borne BE, Biesma B, Vincent A, van der Noort V, Aerts JG; NVALT study group.

Ann Oncol. 2015 Nov;26(11):2286-93. doi: 10.1093/annonc/mdv370. Epub 2015 Sep 7.

PMID:
26347109
11.

Rebuttal From Dr Li et al.

Li WW, Burgers JA, Klomp HM, Hartemink KJ.

Chest. 2015 Dec;148(6):1380-1381. doi: 10.1378/chest.15-1197. No abstract available.

PMID:
26110719
12.

COUNTERPOINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? No.

Li WW, Burgers JA, Klomp HM, Hartemink KJ.

Chest. 2015 Dec;148(6):1375-1379. doi: 10.1378/chest.15-1196. No abstract available.

PMID:
26110487
13.

Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.

Damhuis RA, Khakwani A, De Schutter H, Rich AL, Burgers JA, van Meerbeeck JP.

Lung Cancer. 2015 Aug;89(2):212-7. doi: 10.1016/j.lungcan.2015.05.014. Epub 2015 May 22.

PMID:
26044908
14.

Comments on predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion.

Boshuizen RC, Burgers JA, van den Heuvel MM.

Chest. 2015 Jun;147(6):e232. doi: 10.1378/chest.15-0253. No abstract available.

PMID:
26033142
15.

Differential motion between mediastinal lymph nodes and primary tumor in radically irradiated lung cancer patients.

Schaake EE, Rossi MM, Buikhuisen WA, Burgers JA, Smit AA, Belderbos JS, Sonke JJ.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):959-66. doi: 10.1016/j.ijrobp.2014.07.038. Epub 2014 Oct 18.

PMID:
25585787
16.

[Is one single exposure to asbestos life-threatening?].

Baas P, Burgers JA.

Ned Tijdschr Geneeskd. 2014;158:A7653. Dutch.

PMID:
24780577
17.

The effect of St John's wort on the pharmacokinetics of docetaxel.

Goey AK, Meijerman I, Rosing H, Marchetti S, Mergui-Roelvink M, Keessen M, Burgers JA, Beijnen JH, Schellens JH.

Clin Pharmacokinet. 2014 Jan;53(1):103-10. doi: 10.1007/s40262-013-0102-5.

PMID:
24068654
18.

The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.

Boons CC, VAN Tulder MW, Burgers JA, Beckeringh JJ, Wagner C, Hugtenburg JG.

Anticancer Res. 2013 Sep;33(9):3553-61. Review.

PMID:
24023280
19.

Do videos improve website satisfaction and recall of online cancer-related information in older lung cancer patients?

Bol N, Smets EM, Rutgers MM, Burgers JA, de Haes HC, Loos EF, van Weert JC.

Patient Educ Couns. 2013 Sep;92(3):404-12. doi: 10.1016/j.pec.2013.06.004. Epub 2013 Jun 30.

PMID:
23820196
20.

The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.

Goey AK, Meijerman I, Rosing H, Burgers JA, Mergui-Roelvink M, Keessen M, Marchetti S, Beijnen JH, Schellens JH.

Br J Clin Pharmacol. 2013 Sep;76(3):467-74. doi: 10.1111/bcp.12159.

21.

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.

Buikhuisen WA, Burgers JA, Vincent AD, Korse CM, van Klaveren RJ, Schramel FM, Pavlakis N, Nowak AK, Custers FL, Schouwink JH, Gans SJ, Groen HJ, Strankinga WF, Baas P.

Lancet Oncol. 2013 May;14(6):543-51. doi: 10.1016/S1470-2045(13)70125-6. Epub 2013 Apr 12.

PMID:
23583604
22.

Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus.

Blaauwgeers JL, Kappers I, Klomp HM, Belderbos JS, Dijksman LM, Smit EF, Postmus PE, Paul MA, Oosterhuis JW, Hartemink KJ, Vos CG, Burgers JA, Dahele M, Phernambucq EC, Witte BI, Thunnissen E.

Virchows Arch. 2013 May;462(5):547-56. doi: 10.1007/s00428-013-1404-6. Epub 2013 Apr 3.

PMID:
23549732
23.

Legal claims for malignant mesothelioma: dealing with all cases.

van der Bij S, Baas P, van de Vijver MJ, de Mol BA, Burgers JA.

Lung Cancer. 2013 May;80(2):153-8. doi: 10.1016/j.lungcan.2013.01.012. Epub 2013 Feb 15.

PMID:
23415607
24.

Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue.

Lankheet NA, Schaake EE, Rosing H, Burgers JA, Schellens JH, Beijnen JH, Huitema AD.

Bioanalysis. 2012 Nov;4(21):2563-77. doi: 10.4155/bio.12.235.

PMID:
23173792
25.

Talc instillation consensus AIDS differentiating successful from unsuccessful pleurodesis: a survey on the interpretation of pleural approximation after chest tube placement.

Boshuizen RC, Vincent AD, Kunst PW, Burgers JA, van den Heuvel MM.

Respiration. 2013;85(1):85-6. doi: 10.1159/000343427. Epub 2012 Nov 16. No abstract available.

26.

Mediastinal lymph node position variability in non-small cell lung cancer patients treated with radical irradiation.

Schaake EE, Belderbos JS, Buikhuisen WA, Rossi MM, Burgers JA, Sonke JJ.

Radiother Oncol. 2012 Nov;105(2):150-4. doi: 10.1016/j.radonc.2012.09.007. Epub 2012 Oct 22.

PMID:
23089305
27.

A clinical audit in a multidisciplinary care path for thoracic surgery: an instrument for continuous quality improvement.

Numan RC, Klomp HM, Li W, Buitelaar DR, Burgers JA, Van Sandick JW, Wouters MW.

Lung Cancer. 2012 Dec;78(3):270-5. doi: 10.1016/j.lungcan.2012.08.006. Epub 2012 Sep 20.

PMID:
22999081
28.

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.

Tiseo M, Giovannetti E, Tibaldi C, Camerini A, Di Costanzo F, Barbieri F, Burgers JA, Vincent A, Peters GJ, Smit EF, Ardizzoni A.

Lung Cancer. 2012 Oct;78(1):92-9. doi: 10.1016/j.lungcan.2012.07.009. Epub 2012 Aug 11.

PMID:
22889494
29.

Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer.

Schaake EE, Kappers I, Codrington HE, Valdés Olmos RA, Teertstra HJ, van Pel R, Burgers JA, van Tinteren H, Klomp HM.

J Clin Oncol. 2012 Aug 1;30(22):2731-8. doi: 10.1200/JCO.2011.39.4882. Epub 2012 Jul 2.

PMID:
22753915
30.

Prognosis and prognostic factors of patients with mesothelioma: a population-based study.

van der Bij S, Koffijberg H, Burgers JA, Baas P, van de Vijver MJ, de Mol BA, Moons KG.

Br J Cancer. 2012 Jun 26;107(1):161-4. doi: 10.1038/bjc.2012.245. Epub 2012 May 29.

31.

Population-based survival for malignant mesothelioma after introduction of novel chemotherapy.

Damhuis RA, Schroten C, Burgers JA.

Eur Respir J. 2012 Jul;40(1):185-9. doi: 10.1183/09031936.00153611. Epub 2011 Dec 1.

32.

Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008.

Koning CC, Aarts MJ, Struikmans H, Poortmans PM, Lybeert ML, Jobsen JJ, Coebergh JW, Janssen-Heijnen ML, Visser O, Louwman WJ, Burgers JA.

Clin Oncol (R Coll Radiol). 2012 Mar;24(2):e46-53. doi: 10.1016/j.clon.2011.06.010. Epub 2011 Jul 22.

PMID:
21782398
33.

Concurrent high-dose radiotherapy with low-dose chemotherapy in patients with non-small cell lung cancer of the superior sulcus.

Kappers I, Klomp HM, Koolen MG, Uitterhoeve LJ, Kloek JJ, Belderbos JS, Burgers JA, Koning CC.

Radiother Oncol. 2011 Nov;101(2):278-83. doi: 10.1016/j.radonc.2011.05.030. Epub 2011 Jun 30.

PMID:
21723638
34.

Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine.

Joerger M, Burgers JA, Baas P, Doodeman VD, Smits PH, Jansen RS, Vainchtein LD, Rosing H, Huitema AD, Beijnen JH, Schellens JH.

Cancer Chemother Pharmacol. 2012 Jan;69(1):25-33. doi: 10.1007/s00280-011-1670-4. Epub 2011 May 18.

PMID:
21590444
35.

Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.

Joerger M, deJong D, Burylo A, Burgers JA, Baas P, Huitema AD, Beijnen JH, Schellens JH.

Lung Cancer. 2011 Nov;74(2):310-7. doi: 10.1016/j.lungcan.2011.03.016. Epub 2011 Apr 29.

PMID:
21529986
36.

Markers for the non-invasive diagnosis of mesothelioma: a systematic review.

van der Bij S, Schaake E, Koffijberg H, Burgers JA, de Mol BA, Moons KG.

Br J Cancer. 2011 Apr 12;104(8):1325-33. doi: 10.1038/bjc.2011.104. Epub 2011 Mar 29. Review.

37.

Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?

Burgers JA, Fong SL, Louwers YV, Valkenburg O, de Jong FH, Fauser BC, Laven JS.

J Clin Endocrinol Metab. 2010 Dec;95(12):E485-9. doi: 10.1210/jc.2009-2717. Epub 2010 Sep 15.

PMID:
20843954
38.

Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?

Buikhuisen WA, Burgers JA, Vincent AD, Schellens JH, Beijnen JH, Smit EF, Joerger M.

J Clin Oncol. 2010 Sep 20;28(27):e482-3; author reply e484. doi: 10.1200/JCO.2010.29.1559. Epub 2010 Jul 6. No abstract available.

PMID:
20606096
39.

Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib.

Giovannetti E, Zucali PA, Peters GJ, Cortesi F, D'Incecco A, Smit EF, Falcone A, Burgers JA, Santoro A, Danesi R, Giaccone G, Tibaldi C.

Mol Cancer Ther. 2010 Mar;9(3):581-93. doi: 10.1158/1535-7163.MCT-09-0665. Epub 2010 Feb 16.

40.

Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection.

Kappers I, van Sandick JW, Burgers JA, Belderbos JS, Wouters MW, van Zandwijk N, Klomp HM.

Eur J Cardiothorac Surg. 2009 Oct;36(4):741-6. doi: 10.1016/j.ejcts.2009.04.069. Epub 2009 Aug 21.

PMID:
19699647
41.

Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.

De Bruin ML, Burgers JA, Baas P, van 't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Aleman BM, van Leeuwen FE.

Blood. 2009 Apr 16;113(16):3679-81. doi: 10.1182/blood-2008-10-184705. Epub 2009 Feb 20.

42.

Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.

Geurts TW, Balm AJ, van Velthuysen ML, van Tinteren H, Burgers JA, van Zandwijk N, Klomp HM.

Head Neck. 2009 Feb;31(2):220-6. doi: 10.1002/hed.20952.

PMID:
18972427
43.

Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer.

Kappers I, Klomp HM, Burgers JA, Van Zandwijk N, Haas RL, van Pel R.

J Clin Oncol. 2008 Sep 1;26(25):4205-7. doi: 10.1200/JCO.2008.16.3709. No abstract available.

PMID:
18757336
44.

Pleural drainage and pleurodesis: implementation of guidelines in four hospitals.

Burgers JA, Kunst PW, Koolen MG, Willems LN, Burgers JS, van den Heuvel M.

Eur Respir J. 2008 Nov;32(5):1321-7. doi: 10.1183/09031936.00165607. Epub 2008 Jul 9.

45.

Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients.

Kappers I, Belderbos JS, Burgers JA, van Zandwijk N, Groen HJ, Klomp HM.

Lung Cancer. 2008 Mar;59(3):385-90. Epub 2007 Oct 25.

PMID:
17913281
46.

[Chronic indwelling pleural catheter for malignant pleural effusion in 25 patients].

Burgers JA, Olijve A, Baas P.

Ned Tijdschr Geneeskd. 2006 Jul 22;150(29):1618-23. Dutch.

PMID:
16901066
47.

Occupational asbestos exposure: how to deal with suspected mesothelioma cases--the Dutch approach.

Baas P, van 't Hullenaar N, Wagenaar J, Kaajan JP, Koolen M, Schrijver M, Schlösser N, Burgers JA.

Ann Oncol. 2006 May;17(5):848-52. Epub 2006 Feb 24.

PMID:
16500906
48.

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.

Baas P, Belderbos JS, Senan S, Kwa HB, van Bochove A, van Tinteren H, Burgers JA, van Meerbeeck JP.

Br J Cancer. 2006 Mar 13;94(5):625-30.

49.

[Problematic cases of mesothelioma reported to the Dutch Institute for Asbestos Victims: evaluation by the Mesothelioma Working Group of the Netherlands Association of Pulmonologists and Specialists in Tuberculosis].

Baas P, Sleeswijk P, Strankinga WF, van Hezik EJ, Burgers JA, Tan KY, Schouwink JH.

Ned Tijdschr Geneeskd. 2005 Apr 2;149(14):759-63. Dutch.

PMID:
15835628
50.

[Development in the treatment of malignant mesothelioma].

Bass P, Burgers JA.

Ned Tijdschr Geneeskd. 2005 Apr 2;149(14):747-53. Review. Dutch.

PMID:
15835625

Supplemental Content

Loading ...
Support Center